Archive for January 24, 2017

Review – Role of cephalosporins in the era of Clostridium difficile infection

Journal of Antimicrobial Chemotherapy January 2017 V.72 N.1 P. 1-18

Mark H. Wilcox; James D. Chalmers; Carl E. Nord; Jane Freeman; Emilio Bouza

The incidence of Clostridium difficile infection (CDI) in Europe has increased markedly since 2000. Previous meta-analyses have suggested a strong association between cephalosporin use and CDI, and many national programmes on CDI control have focused on reducing cephalosporin usage. Despite reductions in cephalosporin use, however, rates of CDI have continued to rise. This review examines the potential association of CDI with cephalosporins, and considers other factors that influence CDI risk. EUCLID (the EUropean, multicentre, prospective biannual point prevalence study of CLostridium difficile Infection in hospitalized patients with Diarrhoea) reported an increase in the annual incidence of CDI from 6.6 to 7.3 cases per 10 000 patient bed-days from 2011–12 to 2012–13, respectively. While CDI incidence and cephalosporin usage varied widely across countries studied, there was no clear association between overall cephalosporin prescribing (or the use of any particular cephalosporin) and CDI incidence. Moreover, variations in the pharmacokinetic and pharmacodynamic properties of cephalosporins of the same generation make categorization by generation insufficient for predicting impact on gut microbiota. A multitude of additional factors can affect the risk of CDI. Antibiotic choice is an important consideration; however, CDI risk is associated with a range of antibiotic classes. Prescription of multiple antibiotics and a long duration of treatment are key risk factors for CDI, and risk also differs across patient populations. We propose that all of these are factors that should be taken into account when selecting an antibiotic, rather than focusing on the exclusion of individual drug classes.

FULL TEXT

https://academic.oup.com/jac/article/72/1/1/2643139/Role-of-cephalosporins-in-the-era-of-Clostridium

PDF

http://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jac/72/1/10.1093_jac_dkw385/3/dkw385.pdf?Expires=1485599756&Signature=SddUPWXGgMIOXumKQr~qwNbCCMxsK8SI2aZVv0uL-tQpcHQXAjZGqgaF-JwVD0zdothcR0oHpy7YxjIXxOHKBLyTs1AWogBxAKbIw~YoEBxpodh~dPhFEWIX4DQ21EgUHCpEL5RWCCEUgCc8OSWe5So2NuUc~TYUPuHbcKVkWII~FWDqAFTjhzQ4zHBQjynBNavwak6qKUDIsMt5ZVatILj2ojFwALSL0EMe14CdE5iD-hOrfocqBpltMzG3Nm1TqVyGfkeXJ5V7xhE6Gq-CWaMkN8nIApRi2-BeZ2cs9A7p6ILOCUkp2FUSf5BNw-0RCizaK2v8SA3zFJCdwoUqFw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q

Advertisements

January 24, 2017 at 8:09 am

Analysis of linezolid and tigecycline as candidates for local prophylaxis via antibiotic-loaded bone cement

Journal of Antimicrobial Chemotherapy February 2017 V.72 N.2 P.410–416

EDITOR’S CHOICE

Nichol; T. J. Smith; R. Townsend; I. Stockley; R. Akid

Objectives

To assess the Gram-positive-specific antibiotic linezolid and the broad-spectrum antibiotic tigecycline for use in local antibiotic delivery via antibiotic-loaded bone cement.

Methods

Linezolid and tigecycline were added to Biomet bone cement at varying concentrations. Antibiotic elution over 1 week was quantified by HPLC-MS. The effect of wear on elution over 51 h was determined using a modified TE-66 wear tester. Eluted antibiotics were used to determine the MICs for a panel of clinically relevant bacteria. The impact strength of antibiotic-loaded samples was determined using a Charpy-type impact testing apparatus. Cytotoxicity of eluted antibiotics against MG-63 cells was evaluated using an MTT assay.

Results

Linezolid and tigecycline eluted from bone cement to clinically relevant levels within 1 h and retained activity over 1 week. Mechanical wear significantly reduced elution of tigecycline, but had little effect on elution of linezolid. Linezolid showed low cytotoxicity towards MG-63 cells with ≤300 mg/mL resulting in >50% cell activity. Cytotoxicity of tigecycline was higher, with an IC50 of 5–10 mg/L.

Conclusions

Linezolid and tigecycline retain activity after elution from bone cement. The concentration of tigecycline may need to be carefully controlled due to cytotoxicity. The effect of wear on bone cement may need to be considered if tigecycline is to be used for local delivery. Up to 10% linezolid can be added without affecting the impact strength of the bone cement. These results are promising indications for future investigation of these antibiotics for use in local antibiotic delivery strategies.

FULL TEXT

https://academic.oup.com/jac/article/72/2/410/2290944/Analysis-of-linezolid-and-tigecycline-as

PDF

http://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jac/72/2/10.1093_jac_dkw410/3/dkw410.pdf?Expires=1485599246&Signature=KwUBK1~CIeGnAogtq1WNjsOKzrTY-QCiw9Q79t2l-CX6rqIV5Bu0xhqwV5VmwVgL9JFDusD1Tl82Il1Q3Qrc21IJjKbOfcgpdIGIVUPlWJ0tWkJ5k1aQ3oXYoiwpIUaYoUS7Jr7Lt7mlYfc~e44UslkOk6U0LCih311wG~EYHXrm2BR-MD-hL4KMIYwcb-hxxAeubHhnoJxcktSrkI1wHLEMvz9OmqKNLDkPj7DEjG2ghZ-2F3tCCka98J4M3DmuEPlhtrwSjPYYCJ9V~0-CWkSEb-eYqa5wX9LeG4BOV-eyBf861aSp2tw5ZhqHuMkeHFxdRc7Vv9iFsEk590EWmQ__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q

January 24, 2017 at 8:07 am

Linezolid: a promising option in the treatment of Gram-positives

Journal of Antimicrobial Chemotherapy February 2017 V.72 N.2 P.354-364

EDITOR’S CHOICE

Abed Zahedi Bialvaei; Mohammad Rahbar; Mehdi Yousefi; Mohammad Asgharzadeh; Hossein Samadi Kafil

Linezolid, an oxazolidinone antimicrobial agent that acts by inhibiting protein synthesis in a unique fashion, is used in the treatment of community-acquired pneumonia, skin and soft-tissue infections and other infections caused by Gram-positive bacteria including VRE and methicillin-resistant staphylococci. Currently, linezolid resistance among these pathogens remains low, commonly <1.0%, although the prevalence of antibiotic resistance is increasing in many countries. Therefore, the development of resistance by clinical isolates should prompt increased attention of clinical laboratories to routinely perform linezolid susceptibility testing for this important agent and should be taken into account when considering its therapeutic use. Considering the importance of linezolid in the treatment of infections caused by Gram-positive bacteria, this review was undertaken to optimize the clinical use of this antibiotic.

FULL TEXT

https://academic.oup.com/jac/article/72/2/354/2629138/Linezolid-a-promising-option-in-the-treatment-of

PDF

http://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jac/72/2/10.1093_jac_dkw450/3/dkw450.pdf?Expires=1485598900&Signature=DisJQGUsorrLUDp-sDszDUEUYEajo9HeKCrt0Umqt6qYyI0Dp9~OUIXsMvqCBsWB599D48H6ayDvc4KCh-DYdf3wj8saww27~YgW9iHo~0Ztcny~w0nc3ttWcYFL0QiPlczKUoNz5wjjjDkAdZCPDnql96itmZcRv-10e~rtxNjNtZqSMzXaG-rzlQfT23b~6WOBYcoa0Cs1FSQ7M5qtP0Hnm~x0ynrK~uq30o-rGZVNubLk05cRLIl3pX0jeF28x8u-XoUCk3JoWLJTBiPyubX~euVpZPE2hgn4zmSD1wkjlIoZp3cKpHXOtKEGGdwyi-mJuq2dOCRHU0DJLk3HBw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q

January 24, 2017 at 8:05 am


Calendar

January 2017
M T W T F S S
« Dec   Feb »
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Posts by Month

Posts by Category